Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01539486 · ClinicalTrials.gov registry record

Relationship of Preoperative Parathyroid Hormone (PTH) and Ex-Vivo Gamma Counts in Minimally Invasive Parathyroidectomy

A clinical trial, sponsored by University of Arkansas.

Completed
Registry status
29
Enrollment target

NCT01539486 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 29 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01539486 has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
29 participants
Enrollment target

Study Summary

The intent for this study is to do a retrospective chart review of all patients who have undergone minimally invasive parathyroidectomy for primary hyperthyroidism. All data collected will be recorded under assigned identification numbers that will have no association with medical record or hospital numbers. Identifying characteristics will include age and sex. Anonymity will be upheld. The patient/family will not be contacted directly. All information will be obtained from the medical chart. Demographics, location, preoperative PTH levels and intraoperative Ex-Vivo gamma counts, co-morbid conditions, and the outcome based on the hospital notes will be obtained from patients' charts and will be transferred to a secure database. It is our hypothesis that there is a linear relationship between immediate preoperative parathyroid hormone (PTH) levels and Ex-Vivo gamma counts and the aim of this study is to better describe this relationship.

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2010-01
Est. Completion 2022-12

Sponsor

University of Arkansas

318 total trials

What the Registry Record Tells You About NCT01539486

The ClinicalTrials.gov registry entry for NCT01539486 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01539486 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01539486 about?

NCT01539486 is a clinical study titled "Relationship of Preoperative Parathyroid Hormone (PTH) and Ex-Vivo Gamma Counts in Minimally Invasive Parathyroidectomy". The intent for this study is to do a retrospective chart review of all patients who have undergone minimally invasive parathyroidectomy for primary hyperthyroidism. All data collected will be recorded under assigned identification numbers that will have no association with medical record or hospital...

What is the current status of trial NCT01539486?

This trial is currently completed. The enrollment target is 29 participants. The study started on 2010-01. Estimated completion is 2022-12.

Who is sponsoring clinical trial NCT01539486?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.